The implantation of overlapping stents is a common technique in clinical practice for the treatment of long lesions or as a bail-out strategy in case of stent edge dissection or incomplete plaque coverage. The use of overlap is supported by evidence showing unacceptably high neointimal proliferation and restenosis rates when a gap is left between adjacent stents1.
However, during the bare metal stent (BMS) and the first drug-eluting stent (DES) era, overlap was reported to be a site of increased late lumen loss and was associated with a higher rate of target lesion revascularisation (TLR) and thrombosis compared ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com